Maternal COVID-19 Vaccination Provides Some Protection for Infants
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 2, 2023 -- Maternal COVID-19 vaccination provides some protection against COVID-19-related hospitalization among infants, especially those aged younger than 3 months, according to research published in the Sept. 29 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Regina M. Simeone, Ph.D., from the CDC in Atlanta, and colleagues conducted a case-control study to examine the effectiveness of maternal receipt of a COVID-19 vaccine dose during pregnancy against COVID-19-related hospitalization among infants aged younger than 6 months and a subset aged younger than 3 months. Vaccine effectiveness (VE) was compared for case patients (infants hospitalized for COVID-19 with a positive severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] test result) and control patients (infants hospitalized for COVID-19-like illness with a negative SARS-CoV-2 result). The odds of receipt of maternal COVID-19 vaccine dose during pregnancy were compared to maternal nonvaccination between case and control patients.
The researchers found that the VE of maternal vaccination during pregnancy was 35 and 54 percent against COVID-19-related hospitalization among infants aged younger than 6 months and younger than 3 months, respectively. Intensive care unit admissions occurred in 23 percent of case patients; invasive mechanical ventilation was more common for infants of unvaccinated versus vaccinated mothers (9 versus 1 percent).
"Expectant mothers should be counseled to remain current with COVID-19 vaccination to protect themselves and their infants from hospitalization and severe outcomes associated with COVID-19," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Further Support and Information on COVID-19
Read this next
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
FRIDAY, June 14, 2024 -- There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by...
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
THURSDAY, June 13, 2024 -- For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19...
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB Response
TUESDAY, June 11, 2024 -- Short-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.